Analgesic and antisympathetic effects of clonidine in burn patients, a randomized, double-blind, placebo-controlled clinical trial

ABSTRACT

Objectives:Unlike most other Analgesic drugs, α2 adrenoceptor agonists are capable of producing analgesia. The aim of this study was to evaluate the Analgesic and antisympathetic effects of clonidine, an α2 adrenoceptor agonist in burn patients.Materials and Methods:This randomized, double-blind, placebo-controlled clinical trial performed on one hundred burn patients in Zarea Hospital, Mazandaran, Iran from august 2004 to July 2005. All patients divided in two groups. Case group (n=50) received oral clonidine, 3.3μg/kg TDS and controls (n=50) received placebo. Heart rate and systolic blood pressure and pain severity Visual analogue score (VAS), were recorded after clonidine administration. Statistical analysis was done by means of Mann Witney U test. Results:50 patients (mean age 28.96±10 years) in case group, and 50 patients (mean age 27.60±11.4 years) in control group were studied. VAS pain scores and heart rate in the clonidine group were significantly lower than the control group (P< 0.0001, P< 0.02).there were no significant difference in systolic blood pressure between the two groups on the first and second day but on third day the systolic blood pressure in clonidine group, was lower than controls significantly (P=0.002). Conclusion: This study demonstrates that the use of oral clonidine affects the hemodynamic response to pain in burn patients. Our study demonstrated that clonidine can produce good analgesia and decreased in sympathetic over activity in burn patients, and also reduce opioid dose requirements.

KEY WORDS

Clonidine - analgesia - sedation

• 1 Loncar Z, Bras M, Mickovic V. The relationships between burn pain, anxiety and depression. Coll Antropol 2006; 30: 319-25
• 2 Jellish WS, Gamelli RL, Furry PA, McGill VL, Fluder EM. Effect of topical local anesthetic application to skin harvestsites for pain management in burn patients undergoing skin-grafting procedures. Ann Surg. 1999; 229: 115-20
• 3 Ashburn MA. Burn pain: The management of procedure-related pain. J Burn Care Rehab 1995; 16: 365-71
• 4 Lewis KS, Whipple JK, Michael KA, Quebbeman EJ. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm 1994; 51: 1539-54
• 5 Martin J, Parsch A, Franck M, Wernecke KD, Fischer M, Spies C. Practice of sedation and analgesia in German intensive care units:Results of a national survey. Crit Care 2005; 9: R117-23
• 6 Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114: 541-8
• 7 Durbin Jr CG. Sedation in the critically ill patient. New Horiz 1994; 2: 64-74
• 8 Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: A systematic review. JAMA 2000; 283: 1451-9
• 9 Homma M, Sumiya K, Kambayashi Y, Inomata S, Kohda Y. Assessment of clonidine orally disintegrating tablet for pre-anesthetic medication in pediatric surgery. Biol Pharm Bull 2006; 29: 321-3
• 10 Bernard JM, Ottmar K, Bonnet F. Comparison of intravenous and epidural clonidinefor postoperative patient-controlled analgesia. Anesth Analg 1995; 81: 706-12
• 11 Kariya N, Shindoh M, Nishi S, Yukioka H, Asada A. Oral Clonidine for sedation and analgesia in a burn patient. J Clin Anesth 1998; 10: 514-7
• 12 Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90: 699-705
• 13 Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83: 372-80
• 14 Thornton C, Lucas MA, Newton DE, Dore CJ, Jones RM. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2: Auditory and somatosensory evoked responses. Br J Anaesth 1999; 83: 381-6
• 15 Thomson IR, Peterson MD, Hudson RJ. A comparison of clonidine with conventional preanesthetic medication in patients undergoing coronaryartery bypass grafting. Anesth Analg 1998; 87: 292-9
• 16 Latarjet J, Choiniere M. Pain in burn patients. Burn 1995; 21: 344-8
• 2 Cassuto J, Tarnow P, Yregard L, Lindblom L, Rantfors J. Regulation of postburn ischemia by α- and β-adrenoceptor subtypes. Burns 2005; 31: 131-7
• 18 Pal SK, Cortiella J, Herndon D. Adjunctive methods of pain control in burns. Burns 1997; 23: 404-12
• 19 Viggiano M, Badetti C, Roux F, Mendizabal H, Bernini V, Manelli JC. Controlled analgesia in a burn patient: Fentanyl sparing effect of clonidine. Ann Fr Anesth Reanim 1998; 17: 19-26
• 20 Lyons B, Casey W, Doherty P, McHugh M, Moore KP. Pain relief with low-dose intravenous clonidine in a child with severe burns. Intensive Care Med 1996; 22: 249-51
• 21 Ashburn MA. Burn pain: The management of procedure-related pain. J Burn Care Rehab 1995; 16: 365-71
• 22 Cassuto J, Tarnow P, Yregard L, Lindblom L, Rantfors J. Regulation of postburn ischemia by alpha- and beta-adrenoceptor subtypes. Burns 2005; 31: 131-7
• 23 Cassuto J, Tarnow P, Yregard L, Lindblom L, Rantfors J. Adrenoceptor subtypes in the control of burn-induced plasma extravasation. Burns 2005; 31: 123-9
• 24 Tryba M, Kulka PJ. Critical care pharmacotherapy. A review. Drugs 1993; 45: 338-52